Winton Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-76,061	Closed	-$69K	–	893
2025 Q2	$69K	Buy	+76,061	New	+$45.1K	﹤0.01%	795
2021 Q4	–	Sell	-62,869	Closed	-$158K	–	1230
2021 Q3	$158K	Buy	62,869 +9,260	+17%	+$23.8K	0.01%	1263
2021 Q2	$153K	Buy	53,609 +9,596	+22%	+$24.8K	0.01%	1368
2021 Q1	$103K	Buy	44,013 +9,242	+27%	+$22.2K	0.01%	1332
2020 Q4	$61K	Sell	34,771 -32,761	-49%	-$45.8K	﹤0.01%	1282
2020 Q3	$63K	Sell	67,532 -40,748	-38%	-$36K	﹤0.01%	1434
2020 Q2	$94K	Sell	108,280 -10,655	-9%	-$9.38K	﹤0.01%	1405
2020 Q1	$98K	Sell	118,935 -40,416	-25%	-$40.3K	﹤0.01%	1326
2019 Q4	$142K	Buy	+159,351	New	+$133K	﹤0.01%	1473